T-cell acute lymphoblastic lymphoma
Clinical trials for T-cell acute lymphoblastic lymphoma explained in plain language.
Never miss a new study
Get alerted when new T-cell acute lymphoblastic lymphoma trials appear
Sign up with your email to follow new studies for T-cell acute lymphoblastic lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New universal CAR t therapy targets tough blood cancers
Disease control Not yet recruitingThis early-stage trial tests a new type of immune cell therapy (called universal CAR T cells) for people with certain blood cancers, including T-cell leukemia and lymphoma. The therapy targets a protein called CD7 found on cancer cells. The study will check if the treatment is sa…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis study tests a new type of immunotherapy called CAR-T cells that are designed to recognize and attack cancer cells carrying a protein called CD7. It includes people with several blood cancers, such as T-cell acute lymphoblastic leukemia and acute myeloid leukemia. The goal is…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC